-
1
-
-
67650914230
-
AMPK in health and disease
-
Steinberg, G. R.; Kemp, B. E. AMPK in health and disease Physiol. Rev. 2009, 89, 1025-78
-
(2009)
Physiol. Rev.
, vol.89
, pp. 1025-1078
-
-
Steinberg, G.R.1
Kemp, B.E.2
-
2
-
-
34648828532
-
AMP-activated/SNF1 protein kinases: Conserved guardians of cellular energy
-
Hardie, D. G. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy Nat. Rev. Mol. Cell Biol. 2007, 8, 774-785
-
(2007)
Nat. Rev. Mol. Cell Biol.
, vol.8
, pp. 774-785
-
-
Hardie, D.G.1
-
3
-
-
57349094302
-
AMP-activated protein kinase in skeletal muscle: From structure and localization to its role as a master regulator of cellular metabolism
-
Witczak, C. A.; Sharoff, C. G.; Goodyear, L. J. AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism Cell. Mol. Life Sci. 2008, 65, 3737-3755
-
(2008)
Cell. Mol. Life Sci.
, vol.65
, pp. 3737-3755
-
-
Witczak, C.A.1
Sharoff, C.G.2
Goodyear, L.J.3
-
4
-
-
33847072201
-
AMP-activated protein kinase as a drug target
-
Hardie, D. G. AMP-activated protein kinase as a drug target Annu. Rev. Pharmacol. Toxicol. 2007, 47, 185-210
-
(2007)
Annu. Rev. Pharmacol. Toxicol.
, vol.47
, pp. 185-210
-
-
Hardie, D.G.1
-
5
-
-
0032558725
-
Leptin and the regulation of body weight in mammals
-
Friedman, J. M.; Halaas, J. L. Leptin and the regulation of body weight in mammals Nature 1998, 395, 763-770
-
(1998)
Nature
, vol.395
, pp. 763-770
-
-
Friedman, J.M.1
Halaas, J.L.2
-
6
-
-
1842405349
-
Leptin directly alters lipid partitioning in skeletal muscle
-
Muoio, D. M.; Dohm, G. L.; Fiedorek, F. T., Jr.; Tapscott, E. B.; Coleman, R. A. Leptin directly alters lipid partitioning in skeletal muscle Diabetes 1997, 46, 1360-1363
-
(1997)
Diabetes
, vol.46
, pp. 1360-1363
-
-
Muoio, D.M.1
Dohm, G.L.2
Fiedorek Jr., F.T.3
Tapscott, E.B.4
Coleman, R.A.5
-
7
-
-
17944365228
-
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
-
Yamauchi, T.; Kamon, J.; Waki, H.; Terauchi, Y.; Kubota, N.; Hara, K.; Mori, Y.; Ide, T.; Murakami, K.; Tsuboyama-Kasaoka, N.; Ezaki, O.; Akanuma, Y.; Gavrilova, O.; Vinson, C.; Reitman, M. L.; Kagechika, H.; Shudo, K.; Yoda, M.; Nakano, Y.; Tobe, K.; Nagai, R.; Kimura, S.; Tomita, M.; Froguel, P.; Kadowaki, T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat. Med. 2001, 7, 941-946
-
(2001)
Nat. Med.
, vol.7
, pp. 941-946
-
-
Yamauchi, T.1
Kamon, J.2
Waki, H.3
Terauchi, Y.4
Kubota, N.5
Hara, K.6
Mori, Y.7
Ide, T.8
Murakami, K.9
Tsuboyama-Kasaoka, N.10
Ezaki, O.11
Akanuma, Y.12
Gavrilova, O.13
Vinson, C.14
Reitman, M.L.15
Kagechika, H.16
Shudo, K.17
Yoda, M.18
Nakano, Y.19
Tobe, K.20
Nagai, R.21
Kimura, S.22
Tomita, M.23
Froguel, P.24
Kadowaki, T.25
more..
-
8
-
-
0037067666
-
The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways
-
Fryer, L. G.; Parbu-Patel, A.; Carling, D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways J. Biol. Chem. 2002, 277, 25226-25332
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 25226-25332
-
-
Fryer, L.G.1
Parbu-Patel, A.2
Carling, D.3
-
9
-
-
12144291275
-
Thiazolidinediones, like metformin, inhibit respiratory complex I: A common mechanism contributing to their antidiabetic actions?
-
Brunmair, B.; Staniek, K.; Gras, F.; Scharf, N.; Althaym, A.; Clara, R.; Roden, M.; Gnaiger, E.; Nohl, H.; Waldhausl, W.; Furnsinn, C. Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? Diabetes 2004, 53, 1052-1059
-
(2004)
Diabetes
, vol.53
, pp. 1052-1059
-
-
Brunmair, B.1
Staniek, K.2
Gras, F.3
Scharf, N.4
Althaym, A.5
Clara, R.6
Roden, M.7
Gnaiger, E.8
Nohl, H.9
Waldhausl, W.10
Furnsinn, C.11
-
10
-
-
33744514139
-
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
-
Cool, B.; Zinker, B.; Chiou, W.; Kifle, L.; Cao, N.; Perham, M.; Dickinson, R.; Adler, A.; Gagne, G.; Iyengar, R.; Zhao, G.; Marsh, K.; Kym, P.; Jung, P.; Camp, H. S.; Frevert, E. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome Cell Metab. 2006, 3, 403-16
-
(2006)
Cell Metab.
, vol.3
, pp. 403-416
-
-
Cool, B.1
Zinker, B.2
Chiou, W.3
Kifle, L.4
Cao, N.5
Perham, M.6
Dickinson, R.7
Adler, A.8
Gagne, G.9
Iyengar, R.10
Zhao, G.11
Marsh, K.12
Kym, P.13
Jung, P.14
Camp, H.S.15
Frevert, E.16
-
11
-
-
78650224772
-
A potent and selective AMPK activator that inhibits de novo lipogenesis
-
Gomez-Galeno, J. E.; Dang, Q.; Nguyen, T. H.; Boyer, S. H.; Grote, M. P.; Sun, Z. L.; Chen, M. W.; Craigo, W. A.; van Poelje, P. D.; MacKenna, D. A.; Cable, E. E.; Rolzin, P. A.; Finn, P. D.; Chi, B.; Linemeyer, D. L.; Hecker, S. J.; Erion, M. D. A potent and selective AMPK activator that inhibits de novo lipogenesis ACS Med. Chem.Lett. 2010, 1, 478-482
-
(2010)
ACS Med. Chem.Lett.
, vol.1
, pp. 478-482
-
-
Gomez-Galeno, J.E.1
Dang, Q.2
Nguyen, T.H.3
Boyer, S.H.4
Grote, M.P.5
Sun, Z.L.6
Chen, M.W.7
Craigo, W.A.8
Van Poelje, P.D.9
MacKenna, D.A.10
Cable, E.E.11
Rolzin, P.A.12
Finn, P.D.13
Chi, B.14
Linemeyer, D.L.15
Hecker, S.J.16
Erion, M.D.17
-
12
-
-
77949834465
-
Development of novel adenosine monophosphate-activated protein kinase activators
-
Guh, J. H.; Chang, W. L.; Yang, J.; Lee, S. L.; Wei, S.; Wang, D.; Kulp, S. K.; Chen, C. S. Development of novel adenosine monophosphate-activated protein kinase activators J. Med. Chem. 2010, 53, 2552-2561
-
(2010)
J. Med. Chem.
, vol.53
, pp. 2552-2561
-
-
Guh, J.H.1
Chang, W.L.2
Yang, J.3
Lee, S.L.4
Wei, S.5
Wang, D.6
Kulp, S.K.7
Chen, C.S.8
-
13
-
-
33846945033
-
Conserved alpha-helix acts as autoinhibitory sequence in AMP-activated protein kinase alpha subunits
-
Pang, T.; Xiong, B.; Li, J. Y.; Qiu, B. Y.; Jin, G. Z.; Shen, J. K.; Li, J. Conserved alpha-helix acts as autoinhibitory sequence in AMP-activated protein kinase alpha subunits J. Biol. Chem. 2007, 282, 495-506
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 495-506
-
-
Pang, T.1
Xiong, B.2
Li, J.Y.3
Qiu, B.Y.4
Jin, G.Z.5
Shen, J.K.6
Li, J.7
-
14
-
-
84962393671
-
Ab initio study of 2,4-substituted azolidines. II. Amino-imino tautomerism of 2-aminothiazolidine-4-one and 4-aminothiazolidine-2-one in water solution
-
Enchev, V.; Markova, N.; Angelova, S. Ab initio study of 2,4-substituted azolidines. II. Amino-imino tautomerism of 2-aminothiazolidine-4-one and 4-aminothiazolidine-2-one in water solution J. Phys. Chem. A 2005, 109, 8904-8913
-
(2005)
J. Phys. Chem. A
, vol.109
, pp. 8904-8913
-
-
Enchev, V.1
Markova, N.2
Angelova, S.3
-
15
-
-
0034334762
-
15N NMR and crystal structure studies of 5-(2-pyridylmethylene) pseudothiohydantoin; Dipolar dephasing experiments for establishing the preferred tautomer in the solid and solution states
-
Chowdhry, M. M.; Mingos, D. M. P.; White, A. J. P.; Williams, D. J. 15N NMR and crystal structure studies of 5-(2-pyridylmethylene)pseudothiohydantoin; dipolar dephasing experiments for establishing the preferred tautomer in the solid and solution states J. Chem. Soc., Perkin Trans. 2 2000, 2265-2268
-
(2000)
J. Chem. Soc., Perkin Trans. 2
, pp. 2265-2268
-
-
Chowdhry, M.M.1
Mingos, D.M.P.2
White, A.J.P.3
Williams, D.J.4
-
16
-
-
33344462585
-
Minimising the potential for metabolic activation in drug discovery
-
Kalgutkar, A. S.; Soglia, J. R. Minimising the potential for metabolic activation in drug discovery Expert Opin. Drug Metab. Toxicol. 2005, 1, 91-142
-
(2005)
Expert Opin. Drug Metab. Toxicol.
, vol.1
, pp. 91-142
-
-
Kalgutkar, A.S.1
Soglia, J.R.2
-
17
-
-
19944399431
-
A comprehensive listing of bioactivation pathways of organic functional groups
-
Kalgutkar, A. S.; Gardner, I.; Obach, R. S.; Shaffer, C. L.; Callegari, E.; Henne, K. R.; Mutlib, A. E.; Dalvie, D. K.; Lee, J. S.; Nakai, Y.; O'Donnell, J. P.; Boer, J.; Harriman, S. P. A comprehensive listing of bioactivation pathways of organic functional groups Curr. Drug Metab. 2005, 6, 161-225
-
(2005)
Curr. Drug Metab.
, vol.6
, pp. 161-225
-
-
Kalgutkar, A.S.1
Gardner, I.2
Obach, R.S.3
Shaffer, C.L.4
Callegari, E.5
Henne, K.R.6
Mutlib, A.E.7
Dalvie, D.K.8
Lee, J.S.9
Nakai, Y.10
O'Donnell, J.P.11
Boer, J.12
Harriman, S.P.13
-
18
-
-
33749437211
-
Bioactivation and hepatotoxicity of nitroaromatic drugs
-
Boelsterli, U. A.; Ho, H. K.; Zhou, S.; Leow, K. Y. Bioactivation and hepatotoxicity of nitroaromatic drugs Curr. Drug Metab. 2006, 7, 715-727
-
(2006)
Curr. Drug Metab.
, vol.7
, pp. 715-727
-
-
Boelsterli, U.A.1
Ho, H.K.2
Zhou, S.3
Leow, K.Y.4
-
19
-
-
33750346700
-
Synthesis of 3-(diarylmethylenyl)oxindole by a palladium-catalyzed domino carbopalladation/C-H activation/C-C bond-forming process
-
Pinto, A.; Neuville, L.; Retailleau, P.; Zhu, J. Synthesis of 3-(diarylmethylenyl)oxindole by a palladium-catalyzed domino carbopalladation/C-H activation/C-C bond-forming process Org. Lett. 2006, 8, 4927-30
-
(2006)
Org. Lett.
, vol.8
, pp. 4927-4930
-
-
Pinto, A.1
Neuville, L.2
Retailleau, P.3
Zhu, J.4
-
20
-
-
23644439576
-
Stereoselective synthesis of 3-alkylideneoxindoles via palladium-catalyzed domino reactions
-
Yanada, R.; Obika, S.; Inokuma, T.; Yanada, K.; Yamashita, M.; Ohta, S.; Takemoto, Y. Stereoselective synthesis of 3-alkylideneoxindoles via palladium-catalyzed domino reactions J. Org. Chem. 2005, 70, 6972-6975
-
(2005)
J. Org. Chem.
, vol.70
, pp. 6972-6975
-
-
Yanada, R.1
Obika, S.2
Inokuma, T.3
Yanada, K.4
Yamashita, M.5
Ohta, S.6
Takemoto, Y.7
-
21
-
-
17744380007
-
A tandem Heck-carbocyclization/Suzuki-coupling approach to the stereoselective syntheses of asymmetric 3,3-(diarylmethylene)indolinones
-
Cheung, W. S.; Patch, R. J.; Player, M. R. A tandem Heck- carbocyclization/Suzuki-coupling approach to the stereoselective syntheses of asymmetric 3,3-(diarylmethylene)indolinones J. Org. Chem. 2005, 70, 3741-3744
-
(2005)
J. Org. Chem.
, vol.70
, pp. 3741-3744
-
-
Cheung, W.S.1
Patch, R.J.2
Player, M.R.3
|